UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $4.3M of United Therapeutics Corporation
Sold$4,342,079
$523.14Price
8,300Shares
−16%Stake
What UTHR did after the filing
- The stock from Mon, Aug 24 open, $513.12
- +5.6%
- S&P 500, same days
- +1.9%
Measured over 30 trading days, to the Oct 6 close.
Traded Thu, Aug 20. Filed Fri, Aug 21, 4:43 PM ET, after the close. Returns use the Aug 24 open and the Oct 6 close. Not investment advice.